Anish Mehta

Anish Mehta is the Chief Executive Officer of Synthon, an international pharmaceutical company specializing in developing high-quality generic and hybrid medicines. Anish is also a Board Member at Genie Therapeutics, a gene therapy start-up. Previously, Anish served as the CEO of Theramex, a Women's Health specialty pharmaceuticals company, and held various leadership positions at Allergan, Actavis plc, Baxter, Hospira, McKinsey & Company, and Abbott Laboratories. Mehta holds an MBA from The Wharton School and MS and BS degrees in Engineering from Northwestern University.